ATE405555T1 - Medizinische zusammensetzung, die ein 1,3- thiazinderivat enthält - Google Patents

Medizinische zusammensetzung, die ein 1,3- thiazinderivat enthält

Info

Publication number
ATE405555T1
ATE405555T1 AT02700580T AT02700580T ATE405555T1 AT E405555 T1 ATE405555 T1 AT E405555T1 AT 02700580 T AT02700580 T AT 02700580T AT 02700580 T AT02700580 T AT 02700580T AT E405555 T1 ATE405555 T1 AT E405555T1
Authority
AT
Austria
Prior art keywords
composition containing
medical composition
thiazine derivative
optionally substituted
thiazine
Prior art date
Application number
AT02700580T
Other languages
English (en)
Inventor
Hiroyuki Kai
Takami Murashi
Minoru Tomida
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of ATE405555T1 publication Critical patent/ATE405555T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/04—1,3-Thiazines; Hydrogenated 1,3-thiazines
    • C07D279/06—1,3-Thiazines; Hydrogenated 1,3-thiazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/10—Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT02700580T 2001-03-08 2002-02-14 Medizinische zusammensetzung, die ein 1,3- thiazinderivat enthält ATE405555T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001065386 2001-03-08

Publications (1)

Publication Number Publication Date
ATE405555T1 true ATE405555T1 (de) 2008-09-15

Family

ID=18924048

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02700580T ATE405555T1 (de) 2001-03-08 2002-02-14 Medizinische zusammensetzung, die ein 1,3- thiazinderivat enthält

Country Status (11)

Country Link
US (1) US6916806B2 (de)
EP (1) EP1375489B1 (de)
JP (1) JP4188694B2 (de)
KR (2) KR20060029296A (de)
CN (1) CN1301981C (de)
AT (1) ATE405555T1 (de)
BR (1) BR0207966A (de)
CA (1) CA2440186C (de)
DE (1) DE60228429D1 (de)
MX (1) MXPA03008033A (de)
WO (1) WO2002072562A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001019807A1 (fr) * 1999-09-14 2001-03-22 Shionogi & Co., Ltd. Derives de 2-imino-1,3-thiazine
WO2003070277A1 (fr) * 2002-02-19 2003-08-28 Shionogi & Co., Ltd. Antiprurigineux
CN1867339A (zh) * 2003-08-18 2006-11-22 盐野义制药株式会社 ***素受体拮抗剂的新应用
TW200508211A (en) * 2003-08-26 2005-03-01 Shionogi & Co 2-naphthylimino-1,3-thiazine derivatives
EP1768662A2 (de) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Immunstimulatoren kleiner moleküle und assays für deren nachweis
JPWO2006080287A1 (ja) * 2005-01-25 2008-06-19 塩野義製薬株式会社 ２−アゾリルイミノ−１，３−チアジン誘導体
WO2006080284A1 (ja) * 2005-01-25 2006-08-03 Shionogi & Co., Ltd. ２－置換イミノ－１，３－オキサジン誘導体

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6165894A (ja) 1984-09-08 1986-04-04 Shionogi & Co Ltd チアジンホスホン酸誘導体とその製法および殺虫剤
JPS6229594A (ja) 1985-07-31 1987-02-07 Shionogi & Co Ltd チアジン環を有する有機燐化合物
JPS62120374A (ja) * 1985-11-20 1987-06-01 Yoshitomi Pharmaceut Ind Ltd １，３−チアジンまたは１，３−オキサジン誘導体
NL8702437A (nl) 1987-10-13 1989-05-01 Geo Kinetics B V I O Werkwijze voor het conditioneren van grondmateriaal door elektrokinetische behandeling, elektrisch stroomsysteem voor toepassing van de werkwijze alsmede elektrode-behuizing voor toepassing in het elektrische stroomsysteem.
CA1331757C (en) * 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
US5194434A (en) * 1991-12-03 1993-03-16 Texas A&M University System Use of OB-101 to treat ocular inflammation
CA2245586A1 (en) * 1996-02-06 1997-08-14 Japan Tobacco Inc. Novel compounds and pharmaceutical use thereof
CA2283797A1 (en) 1997-03-18 1998-09-24 Paul Elliot Bender Novel cannabinoid receptor agonists
WO1999002499A1 (fr) 1997-07-11 1999-01-21 Japan Tobacco Inc. Composes quinoline et utilisations de ceux-ci en medecine
DE19837627A1 (de) * 1998-08-19 2000-02-24 Bayer Ag Neue Aminosäureester von Arylsulfonamiden und Analoga
TR200102041T2 (tr) * 1999-01-14 2001-12-21 Bayer Corporation Progesteron reseptör bağlama aktif maddeleri olarak ikameli 2-arilimino heterosaykıllar
WO2001019807A1 (fr) * 1999-09-14 2001-03-22 Shionogi & Co., Ltd. Derives de 2-imino-1,3-thiazine

Also Published As

Publication number Publication date
DE60228429D1 (de) 2008-10-02
US20040116326A1 (en) 2004-06-17
JP4188694B2 (ja) 2008-11-26
MXPA03008033A (es) 2003-12-04
KR20060029296A (ko) 2006-04-05
KR20040007462A (ko) 2004-01-24
CN1514831A (zh) 2004-07-21
KR100642570B1 (ko) 2006-11-10
JPWO2002072562A1 (ja) 2004-07-02
WO2002072562A1 (fr) 2002-09-19
CA2440186A1 (en) 2002-09-19
EP1375489A4 (de) 2005-03-02
CA2440186C (en) 2009-01-13
US6916806B2 (en) 2005-07-12
EP1375489B1 (de) 2008-08-20
CN1301981C (zh) 2007-02-28
BR0207966A (pt) 2004-06-15
EP1375489A1 (de) 2004-01-02

Similar Documents

Publication Publication Date Title
HK1046639A1 (en) Nitroimidazole external preparations for dermatosis
NO953305D0 (no) Antranilsyrederivat
ATE393150T1 (de) 2-imino-1,3-thiazin-derivate
DE69929669D1 (de) Zyklische Amidderivate die Cathepsin K hemmen
ATE190052T1 (de) Thiazolidindione-derivate, ihre herstellung und verwendung
PT807630E (pt) Compostos heterociclicos
DE69511424T2 (de) Antifungale sordaridinderivate
ATE289810T1 (de) Ecteinascidinderivate
PE34996A1 (es) Nuevo derivado de pirrocarbazol
DK0425209T3 (da) Naphtyloxazolidon Derivater
DE69937045D1 (de) Cyclische amidderivate
DE60228429D1 (de) Medizinische zusammensetzung, die ein 1,3-thiazinderivat enthält
DK1031556T3 (da) 2-phenoxyanilinderivater
MXPA03008250A (es) Nuevos derivados de diaminopirazol y colorantes que contienen estos compuestos.
DK1559714T3 (da) Fremgangsmåde til fremstilling af 2-alkyl-3-aminothiophenderivater og 3-aminothiophenderivater
TR200200347T2 (tr) 1,4-İkameli 4,4-diaril sikloheksanlar.
EP1211253A4 (de) Trizyklische dihydrobenzofurane, verfahren zu deren herstellung und mittel
DE69906243D1 (de) 2-Indanmethanolderivate und ihre Verwendung als Riechstoffe
CA2297112A1 (en) Dicyclanil polymorphs and hydrates and their preparation
ATE340175T1 (de) Imidazo(4,5-böchinolinderivate und ihre verwendung als inhibitoren der induzierbaren no- synthase
EP1148059A4 (de) Thiazolpyrimidin-verbindungen, verfahren zu ihrer herstellung und ihre anwendung
DE59905342D1 (de) N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung
TH26544A (th) อนุพันธ์กรด -4 - อัลคิลไทโอ -ไพรมิดิน -5 - อิล อาซีติก

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties